Signal active
Organization
Contact Information
Overview
Uptake Medical develops innovative medical technologies for the treatment of lung diseases. Its first product, InterVapor™, is the first and only approach to endoscopic lung volume reduction for people with severe emphysema that uses the body’s natural healing process without leaving any foreign materials in the lung. In clinical studies, InterVapor has demonstrated clinically meaningful improvements in breathing function, exercise capacity and quality of life.
About
Biotechnology, Health Care, Medical
2005
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Uptake Medical headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $6.5B in funding across 84 round(s). With a team of 11-50 employees, Uptake Medical is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - Uptake Medical, raised $40.3M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
7
7
0
$77.3M
Details
3
Uptake Medical has raised a total of $77.3M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2006 | Early Stage Venture | 9.0M | ||
2010 | Early Stage Venture | 17.5M | ||
2012 | Late Stage Venture | 40.3M |
Investors
Uptake Medical is funded by 38 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Affinity Capital Management | - | FUNDING ROUND - Affinity Capital Management | 40.3M |
Jan Garfinkle | - | FUNDING ROUND - Jan Garfinkle | 40.3M |
Uptake Medical | - | FUNDING ROUND - Uptake Medical | 40.3M |
Arboretum Ventures | - | FUNDING ROUND - Arboretum Ventures | 40.3M |
Recent Activity
There is no recent news or activity for this profile.